MHRA warns of dangers of counterfeit anti-obesity drug alli
By Neil Durham, 27 January 2010
The MHRA is warning of the dangers of buying medicines from unregulated websites after the discovery in the US of counterfeit weight-loss drug alli.
The MHRA has warned against buying medicines online after conterfeit versions of alli were found
The Food and Drugs Administration (FDA) in the US has been working with manufacturer GlaxoSmithKline following the report of counterfeited versions of alli, which could be available potentially to UK internet customers.
Alli is available over-the-counter in the UK with the genuine product containing the active ingredient orlistat.
Testing of the suspected counterfeit product, 60mg alli capsules (120 capsule refill kit), revealed it contained sibutramine instead of orlistat.
The licence for sibutramine was suspended across Europe last week by the EMA following evidence to suggest an increased risk of non-fatal heart attacks and strokes.
Additional Information
Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- Salaried/Lead GPs Malling Health Competitive, role dependant, NHS Pension and defence fees reimbursed, Nationwide
- Newly qualified GP's dr-locums £70 an hour plus, Nationwide
- Full Time Partner (9 sessions) Charnwood Community Medical Group Equal share partner, Loughborough, LEICS
- Locum GP Meddoc Locums £600-£800 A day, London & Essex
Most read
- Health secretary says GPs have 'ethical duty' to save NHS costs
- GPs face 'outcomes targets overload', patient group warns
- LMCs Conference 2012 - Live Blog
- QOF errors trigger £1,000 top ups and clawbacks
- Women to be screened later for cervical cancer in Scotland and Wales
- LMCs conference 2012 - Full coverage
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
